These include (i) METTL3, which increases the glycolytic capacity of HCC cells [98]; (ii) WTAP, which promotes hepatic cancer cells proliferation and tumor growth in vivo [99]; and (iii) the demethylase FTO, which fosters HCC development [100]. This evidence concerns the gene MBD2 and hepatocellular carcinoma.